Please provide your email address to receive an email when new articles are posted on . A low-dose aspirin-induced decrease in fraction of exhaled nitric oxide among patients with aspirin-exacerbated ...

Which clinical screening markers predict aspirin-exacerbated respiratory disease in patients with chronic rhinosinusitis with nasal polyps? Clinical markers correlated with aspirin-exacerbated ...

You might reach for aspirin, ibuprofen, or naproxen to relieve a headache, lower a fever, or ease joint pain from arthritis or another condition. But if you have a disorder known as ...

Study data from a randomized, double-blind, placebo-controlled trial of prasugrel for the treatment of AERD presented at the 2017 AAAAI Annual Meeting. ATLANTA, GA—At the 2017 AAAAI Annual Meeting, ...

Patients with aspirin-exacerbated respiratory disease (AERD) who initiated treatment with dupilumab as an add-on asthma or chronic rhinosinusitis with nasal polyps therapy reported rapid clinical ...

Patients with aspirin-exacerbated respiratory disease (AERD) are typically asked to report their own symptoms to help determine the severity of their acute condition. The self-reports influence ...

Please provide your email address to receive an email when new articles are posted on . Aspirin-exacerbated respiratory disease was found in 16% of patients with chronic rhinosinusitis with nasal ...

Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) today announced an expansion of its pipeline with a new Phase II development program. The Company has initiated the clinical development of Boxaban™ ...

Researchers conducted a retrospective, observational study of 177 patients with CRSwNP from January 1, 2016, to December 29, 2021. Clinical markers correlated with aspirin-exacerbated respiratory ...